Compliance & Regulatory

Sort By: (Newest to Oldest)
Tough Times for Manufacturers - Go to Market Faster with Sales Enablement

Tough Times for Manufacturers – Go to Market Faster with Sales Enablement

Seth Werlinsky
Written by Seth Werlinsky October 8, 2019

Last week, the S&P and Dow suffered their worst losses in over a month, primarily driven by data that showed manufacturing activity had contracted to its lowest point in over 10 years.  And while it is no secret that manufacturing has been facing challenges for some time, it still remains a critically important component of…

Read More
Manufacturing, Buyer's Journey, Compliance & Regulatory, Trending Topics
How Financial Firms Use Technology to Keep Up with Compliance Changes

How Financial Firms Use Technology to Keep Up with Compliance Changes

Alyssa Drury
Written by Alyssa Drury June 25, 2019

The SEC recently made a substantial change to its Customer Relationship Summary that largely went under the radar: the removal of the word “fiduciary” from mandated language RIAs must use to describe their standard of conduct. This is not to say that RIAs cannot use the term “fiduciary” or are unable to tell clients that…

Read More
Asset Management, Wealth Management, Compliance & Regulatory
Personalizing the Buyer's Journey in the Medical Device Industry

Personalizing the Buyer’s Journey in the Medical Device Industry

Jess Cody
Written by Jess Cody October 25, 2018

Personalizing the buyer’s journey is essential for both sales and marketing teams in the medical device industry. With a variety of different people reps need to cater to, materials must be created in a way that addresses each of their unique needs. Distributing the same message to all buyers won’t work in a competitive and…

Read More
Life Sciences, Compliance & Regulatory, Content Strategy
The Cost of Noncompliance to Medical Device Sales & Marketing Teams

The Cost of Noncompliance to Medical Device Sales & Marketing Teams

Jess Cody
Written by Jess Cody September 14, 2018

$1.15 million, $20 million, $100 million. These are all costs associated with fines and fees that medical device companies incur for noncompliance. Here’s another stat. According to data by KPMG, the medical device industry’s global annual sales is forecast to rise to almost $800 billion by 2030. $800 billion. This shows that the medical device…

Read More
Life Sciences, Compliance & Regulatory, Sales Enablement
Seismic Platform’s Compliance with the GDPR

Seismic Platform’s Compliance with the GDPR

Marc Romano
Written by Marc Romano May 21, 2018

Beginning on May 25, companies that collect or process data on European Union citizens will be required to comply with new privacy regulations and protections around that data. The new set of rules, called the General Data Protection Regulation (GDPR), is designed to strengthen protections around personal data and unify the EU under a consolidated…

Read More
Asset Management, Banking, Financial Services, Life Sciences, Other Industries, Technology, Wealth Management, Compliance & Regulatory, Technology & Data, Trending Topics
That's What She Said: The Importance of Brand Integrity in Life Sciences

That’s What She Said: The Importance of Brand Integrity in Life Sciences

Shauna Leighton
Written by Shauna Leighton September 12, 2017

That’s what she said: A classic Michael Scott line from one of my favorite TV series, “The Office”. While I won’t be discussing inappropriate innuendos like Mr. Scott, the “that’s what she said” one-liner can easily translate to how Marketing and Sales communicate, which ultimately affects brand integrity. Hear me out on this. Marketing creates…

Read More
Life Sciences, Compliance & Regulatory, Marketing Efficiency